Comparison of new triton X-100- and tween-ether-treated split-treated vaccines in children.

Split-product vaccines (SPVs) combine the desirable properties of no systemic reactogenicity and adequate immunogenicity when two doses are given. We compared a new Triton X-100 SPV (Connaught Laboratories, Inc.) with the commercially available Tween-ether SPV (Parke-Davis & Co.) in 76 children...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Gross, P A, Ennis, F A, Gaerlan, P F, Denning, C R, Setia, U, Davis, W J, Bisberg, D S
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 1981
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC273983/
https://ncbi.nlm.nih.gov/pubmed/7031085
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia